| J0178 | Injection, aflibercept, 1 mg | 720 | $690 | $496.8K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 6,420 | $30 | $186.2K |
| J3590 | Unclassified biologics | 70 | $1,860 | $137.3K |
| J2778 | Injection, ranibizumab, 0.1 mg | 450 | $170 | $76.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 560 | $100 | $56.4K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 260 | $210 | $55.6K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 510 | $90 | $45K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,120 | $30 | $32.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 190 | $140 | $25.9K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary… | 970 | $30 | $25.1K |